These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7439345)

  • 21. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assignment of agency component for review of premarket applications--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58754-8. PubMed ID: 10115697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk assessment and management as related to evaluation of medical devices: a view from the FDA.
    Callahan TJ; Marlowe DE
    J Long Term Eff Med Implants; 1993; 3(4):269-76. PubMed ID: 10172029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical devices; medical device reporting; baseline reports. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making sense of the food and drug administration.
    Connor JA
    Semin Pediatr Surg; 2006 Nov; 15(4):293-301. PubMed ID: 17055960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Jul; 63(147):40825. PubMed ID: 10181716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standards for humidification and filtration devices.
    Stevens J
    Respir Care Clin N Am; 2006 Jun; 12(2):203-32. PubMed ID: 16828691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of standards in the review of medical devices.
    Ho C; Jensen D; Lacy F; Muni N; Reilly S; Mallis E
    J Electrocardiol; 2005 Oct; 38(4 Suppl):171-4. PubMed ID: 16226095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical devices: the obvious, the readily-accepted, and the surprising.
    Tolomeo DE; Clarke LA
    J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilities strive to comply with new Act. The long-term effects of the Safe Medical Devices Act are still unknown.
    Schuster DK; Butler KH
    Health Prog; 1993 May; 74(4):53-7. PubMed ID: 10125364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Device development and FDA scientific review.
    Pilot LR
    Med Instrum; 1983; 17(5):341-2. PubMed ID: 6646019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Device tracking: user facility responsibilities.
    Shepherd N
    J Clin Eng; 1993; 18(5):441-52. PubMed ID: 10129809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments.
    Fed Regist; 1993 Aug; 58(156):43442-51. PubMed ID: 10127886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.